Sodium Starch Glycolate-Based Pellets Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Sodium Starch Glycolate-Based Pellets

Sodium Starch Glycolate-Based Pellets are pharmaceutical-grade excipient pellets developed using sodium starch glycolate as a key functional component of the pellet system. Sodium starch glycolate is the sodium salt of a carboxymethyl ether of starch and is available in different compendial types, including Type A and Type B, with defined sodium-content and pH ranges. It is a highly hygroscopic, water-swellable starch derivative used primarily for its rapid swelling characteristics in pharmaceutical formulations.

In pelletized form, sodium starch glycolate can provide a convenient multiparticulate excipient system with controlled physical characteristics. The finished pellet properties depend on the composition, pelletization process, particle-size distribution, moisture level and any additional formulation components used during manufacturing.

Sodium Starch Glycolate-Based Pellets can be considered for pharmaceutical formulation development, multiparticulate systems, capsule-filling applications and other oral solid formulation processes where a sodium starch glycolate-based pellet system is required.

Pharmaceutical-Grade Sodium Starch Glycolate-Based Pellets

Sodium starch glycolate has CAS Number 9063-38-1 and is chemically described as starch carboxymethyl ether, sodium salt. The material is a polymeric starch derivative, so it does not have one fixed molecular weight or a conventional single molecular formula applicable to all grades.

Compendial sodium starch glycolate distinguishes between Type A and Type B. Type A contains 2.8–4.2% sodium, while Type B contains 2.0–3.4% sodium. The corresponding pH ranges are 5.5–7.5 for Type A and 3.0–5.0 for Type B.

The pelletized product should therefore identify the applicable sodium starch glycolate type where relevant.

Applications

Sodium Starch Glycolate-Based Pellets can be considered for:

  • Pharmaceutical excipient pellet formulations
  • Multiparticulate oral formulations
  • Capsule-filling applications
  • Pellet-based formulation development
  • Excipient delivery systems
  • Oral solid formulation development
  • Pharmaceutical research and development
  • Bulk pharmaceutical formulation requirements

Pellet Characteristics

The finished pellet can be evaluated for:

  • Particle-size distribution
  • Bulk density
  • Tapped density
  • Flowability
  • Friability
  • Sphericity
  • Moisture content
  • Sodium starch glycolate content
  • Pellet morphology
  • Mechanical strength
  • Microbiological quality

The exact finished-pellet limits should be established according to the actual product specification and manufacturing process.

Why Sodium Starch Glycolate-Based Pellets from Swapnroop?

  • Pharmaceutical-Grade Pellet System – Designed for pharmaceutical formulation applications.
  • Sodium Starch Glycolate-Based Composition – Uses sodium starch glycolate as a key functional excipient component.
  • Multiparticulate Format – Suitable for pellet-based oral formulation development.
  • Controlled Pellet Characteristics – Particle size and physical characteristics can be specified according to application requirements.
  • Formulation Flexibility – Suitable for different excipient-based formulation systems.
  • Capsule-Filling Applications – Suitable for multiparticulate capsule formulation development.
  • Product-Specific Quality Control – Finished pellets can be evaluated according to defined product specifications.
  • Bulk Pharmaceutical Supply – Suitable for commercial formulation requirements.
  • Manufacturer & Supplier Support – Suitable for pharmaceutical formulation and bulk supply requirements.

Detailed Specifications

Parameter Specification
Appearance white to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 10.0%
Residue on Ignition NMT 0.5%
pH (1% Solution) 5.5–7.5
Water Content NMT 10.0%
Get Bulk Quote via WhatsApp